Data for Effect of Mirabegron Treatment on serum lipidome (Study ST001215)
(Analysis AN002026)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this studyMetabolite | F1 | F2 |
---|---|---|
10-HDHA | 1.2573 | 0.7105 |
11,12-diHETrE | 0.9149 | 1.0851 |
11(12)-EET | 0.9284 | 1.2149 |
11-beta-PGF2a/PGF2b | 1.0684 | 0.9316 |
11-dehydro TxB2 | 0.9607 | 1.0786 |
11-HDHA | 1.3122 | 0.6358 |
11-HEPE | 1.1217 | 0.8630 |
11-HETE | 1.2709 | 0.7291 |
12,13-diHOME | 0.9324 | 1.0676 |
12(13)-EpOME | 1.0602 | 0.9398 |
12-HEPE | 1.5501 | 0.3124 |
12-HETE | 1.2188 | 0.7812 |
12-oxoETE | 1.2825 | 0.3408 |
12-oxoLTB4 | 1.2300 | 0.4250 |
13,14-dihydro-15-keto PGA2 | 1.0253 | 0.9578 |
13,14-dihydro-15-keto PGD2 | 1.0600 | 0.9250 |
13,14-dihydro-15-keto PGE2 | 1.4092 | 0.6727 |
13,14-dihydro-15-keto PGF2a | 0.7255 | 1.2745 |
13,14-dihydro PGE1 | 1.0285 | 0.9715 |
13-HDHA | 1.1270 | 0.9093 |
13-HODE | 1.1132 | 0.8868 |
13-HOTrE/13-HOTrE(r) | 1.0484 | 0.9516 |
13-oxoODE | 1.1118 | 0.8882 |
14,15-diHETE | 1.1034 | 0.8819 |
14,15-diHETrE | 0.8555 | 1.1445 |
14(15)-EET | 1.1399 | 0.8729 |
14(15)-EpETE | 1.1408 | 0.7536 |
14-HDHA | 1.3872 | 0.5698 |
15-deoxy-delta12,14-PGD2 | 0.7961 | 1.2549 |
15-deoxy-delta12,14-PGJ2 | 1.0893 | 0.9196 |
15-HEPE | 0.9272 | 1.0624 |
15-HETE | 1.0286 | 0.9685 |
15-HETrE | 1.0471 | 0.9529 |
15-keto-PGE2 | 1.0000 | NA |
15-keto-PGF2a | 1.1461 | 0.9269 |
15-oxoETE | 1.0499 | 0.9501 |
16(17)-EpDPE | 1.0116 | 0.9870 |
16-HDHA | 0.8126 | 1.2498 |
16-HETE | 0.9140 | 1.0860 |
17,18-diHETE | 0.9764 | 1.0236 |
17(18)-EpETE | 1.2542 | 0.8729 |
17-HDHA | 0.7491 | 1.2788 |
17-HETE | 1.2805 | 0.7450 |
18-HEPE | 0.8489 | 1.1133 |
18-HETE | 1.0301 | 0.9781 |
19,20-diHDPA | 0.8661 | 1.1339 |
19(20)-EpDPE | 1.1411 | 0.8871 |
19/20-OH PGE2 | 1.0659 | 0.9561 |
19/20-OH PGF2a | 1.0924 | 0.8984 |
20-carboxy LTB4 | 1.0000 | NA |
20-HDHA | 1.2053 | 0.5895 |
20-HETE | 1.3005 | 0.7541 |
2,3-dinor-11beta-PGF2a | 1.1356 | 0.7288 |
2,3-dinor TxB2 | 0.9230 | 1.1540 |
4-HDHA | 1.2033 | 0.6272 |
5,15-diHETE | 1.0935 | 0.9065 |
5,6-diHETE | 0.5086 | 1.6879 |
5,6-diHETrE | 1.0185 | 0.9852 |
5(6)-EET | 1.0000 | NA |
5-HEPE | 1.0947 | 0.9148 |
5-HETE | 0.9455 | 1.0545 |
5-HETrE | 0.9116 | 1.0796 |
5-iPF2a-VI | 0.9313 | 1.0687 |
5-oxoETE | 1.0564 | 0.9507 |
6,15-diketo-13,14-dihydro PGF1a | 0.9068 | 1.0233 |
6-keto PGE1 | 0.9328 | 1.0480 |
6-keto-PGF1a | 0.9437 | 1.0643 |
7-HDHA | 1.0480 | 0.9712 |
8,9-diHETrE | 0.8211 | 1.1789 |
8(9)-EET | 0.3593 | 1.2136 |
8-HDHA | 1.0650 | 0.9164 |
8-HEPE | 0.9616 | 1.0461 |
8-HETE | 1.1250 | 0.8472 |
8-HETrE | 0.9773 | 1.0249 |
8-iso PGF2a | 0.8764 | 1.1544 |
9,10-diHOME | 0.9839 | 1.0161 |
9(10)-EpOME | 1.1039 | 0.8961 |
9-HEPE | 1.1666 | 0.8889 |
9-HETE | 1.1339 | 0.8513 |
9-HODE | 1.0539 | 0.9461 |
9-HOTrE | 1.1372 | 0.8628 |
9-oxoODE | 1.0643 | 0.9357 |
Bicyclo PGE2 | 0.9919 | 1.0129 |
d4-9-HODE | NA | NA |
d4-LTB4 | NA | NA |
d4-PGE2 | NA | NA |
d8-5S-HETE | NA | NA |
delta12-PGJ2 | 1.1086 | 0.9069 |
Hepoxilin A3 | 0.3761 | 1.9983 |
LTB4 | 1.0614 | 0.9078 |
LTC4 | NA | 1.0000 |
LTD4 | 1.0282 | 0.9577 |
LTE4 | 1.0000 | NA |
LXA4 | 0.8625 | 1.1833 |
LXB4 | 1.2847 | 0.9288 |
Maresin1 | NA | NA |
PD1 | 1.5543 | 0.7228 |
PGA1 | 0.8899 | 1.1468 |
PGA2/PGJ2 | 1.0976 | 0.8862 |
PGB2 | 1.1477 | 0.8523 |
PGD2 | 1.0656 | 0.9181 |
PGD3/PGE3 | 1.2573 | 0.5711 |
PGE1/PGD1 | 1.0200 | 0.9700 |
PGE2/PGD2 | 1.2066 | 0.7727 |
PGF1a | 1.0609 | 0.9391 |
PGF2a | 1.1367 | 0.8438 |
PGK2 | 1.0057 | 0.9924 |
RvD1 | 1.1609 | 0.5978 |
RvD2 | 1.1848 | 0.8152 |
Tetranor-12-HETE | 1.0878 | 0.9122 |
tetranor-PGFM | 1.0871 | 0.9303 |
TxB2 | 1.1726 | 0.8274 |
TxB3 | 0.9657 | 1.0549 |
Factors:
F1 | Treatment:Mirabegron |
F2 | Treatment:Placebo |